Key Details
Annual ROE
-26.34%Beta
-Events Calendar
Next earnings date:
N/ARecent quarterly earnings:
Mar 24, 2023Recent annual earnings:
Mar 24, 2023Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
No data about analysts updates
Screeners with RCOR included
No data
Market Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Renovacor doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Efficiency
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Institutional Ownership
Similar stocks
FAQ
- What is the primary business of Renovacor?
- What is the ticker symbol for Renovacor?
- Does Renovacor pay dividends?
- What sector is Renovacor in?
- What industry is Renovacor in?
- What country is Renovacor based in?
- When did Renovacor go public?
- Is Renovacor in the S&P 500?
- Is Renovacor in the NASDAQ 100?
- Is Renovacor in the Dow Jones?
- When was Renovacor's last earnings report?
- When does Renovacor report earnings?
What is the primary business of Renovacor?
Renovacor, Inc., a biotechnology company, focuses on delivering various precision therapies to enhance the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. It primarily focuses on the treatment of BCL2-associated athanogene 3 (BAG3) mutation-associated dilated cardiomyopathy (DCM). The company's lead product candidate is REN-001, a recombinant adeno-associated virus 9-based gene therapy designed to deliver a functional BAG3 gene to augment BAG3 protein levels in cardiomyocytes, and slow or halt progression of BAG3 DCM. It is also developing a pipeline of BAG3-associated gene therapies for diseases with high unmet medical need associated with mutations in the BAG3 gene and mechanistically linked to BAG3's expression and function. The company was founded in 2013 and is based in Greenwich, Connecticut.
What is the ticker symbol for Renovacor?
The ticker symbol for Renovacor is NYSE American:RCOR
Does Renovacor pay dividends?
No, Renovacor does not pay dividends
What sector is Renovacor in?
Renovacor is in the Healthcare sector
What industry is Renovacor in?
Renovacor is in the Biotechnology industry
What country is Renovacor based in?
Renovacor is headquartered in United States
When did Renovacor go public?
Renovacor's initial public offering (IPO) was on 22 June 2020
Is Renovacor in the S&P 500?
No, Renovacor is not included in the S&P 500 index
Is Renovacor in the NASDAQ 100?
No, Renovacor is not included in the NASDAQ 100 index
Is Renovacor in the Dow Jones?
No, Renovacor is not included in the Dow Jones index
When was Renovacor's last earnings report?
Renovacor's most recent earnings report was on 24 March 2023
When does Renovacor report earnings?
The date for Renovacor's next earnings report has not been announced yet